| Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients M Gentile, TD Shanafelt, D Rossi, L Laurenti, FR Mauro, S Molica, ... Blood, The Journal of the American Society of Hematology 128 (16), 2093-2095, 2016 | 88 | 2016 |
| Complement mediated hemolytic anemias in the COVID-19 era: case series and review of the literature B Fattizzo, R Pasquale, V Bellani, W Barcellini, AG Kulasekararaj Frontiers in Immunology 12, 791429, 2021 | 48 | 2021 |
| Bortezomib in autoimmune hemolytic anemia and beyond R Pasquale, JA Giannotta, W Barcellini, B Fattizzo Therapeutic Advances in Hematology 12, 20406207211046428, 2021 | 31 | 2021 |
| Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: analysis of 1299 newly diagnosed cases M Gentile, TD Shanafelt, FR Mauro, L Laurenti, D Rossi, S Molica, ... Am J Hematol 93 (2), E35-E37, 2018 | 30 | 2018 |
| Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia A Corbingi, I Innocenti, A Tomasso, R Pasquale, A Visentin, M Varettoni, ... British Journal of Haematology 190 (6), 901-908, 2020 | 25 | 2020 |
| Autoimmune hemolytic anemia in chronic lymphocytic leukemia: a comprehensive review F Autore, R Pasquale, I Innocenti, A Fresa, F Sora’, L Laurenti Cancers 13 (22), 5804, 2021 | 21 | 2021 |
| HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis I Innocenti, F Morelli, F Autore, A Corbingi, R Pasquale, F Sorà, M Pompili, ... Leukemia & Lymphoma 60 (5), 1340-1342, 2019 | 18 | 2019 |
| Large granular lymphocyte expansion in myeloid diseases and bone marrow failure syndromes: whoever seeks finds B Fattizzo, V Bellani, R Pasquale, JA Giannotta, W Barcellini Frontiers in Oncology 11, 748610, 2021 | 16 | 2021 |
| Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs B Fattizzo, R Pasquale, M Carpenedo, S Cantoni, G Auteri, D Gramegna, ... haematologica 104 (10), e470, 2019 | 13 | 2019 |
| Novel therapies for unmet clinical needs in myelodysplastic syndromes G Cassanello, R Pasquale, W Barcellini, B Fattizzo Cancers 14 (19), 4941, 2022 | 12 | 2022 |
| Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia I Innocenti, F Autore, R Pasquale, F Morelli, DG Efremov, L Laurenti Expert Review of Hematology 10 (12), 1069-1076, 2017 | 8 | 2017 |
| Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) B Fattizzo, JA Giannotta, W Barcellini, MC Barbanti, C Bucelli, R Cassin, ... Blood Advances 4 (13), 2996-2999, 2020 | 6 | 2020 |
| Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event R Pasquale, C Bucelli, V Bellani, M Zappa, A Iurlo, D Cattaneo Frontiers in Oncology 12, 1012268, 2022 | 4 | 2022 |
| Impact on thrombotic risk of canonical and atypical CALR mutations in essential thrombocythemia. A single-center cohort study S Fabris, D Cattaneo, S Salerio, C Bucelli, G Ciceri, R Pasquale, ... Thrombosis research 210, 67-69, 2022 | 3 | 2022 |
| Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center … I Innocenti, A Fresa, A Tomasso, M Tarnani, L De Padua, G Benintende, ... Cancers 15 (23), 5592, 2023 | 2 | 2023 |
| Aplastic anemia after SARS-CoV-2 infection or vaccines: Case series and literature review B Fattizzo, R Pasquale, GA Croci, L Pettine, G Cassanello, W Barcellini Blood Transfusion 22 (3), 266, 2023 | 2 | 2023 |
| Co-occurrence of myeloid and lymphoid neoplasms: Clinical characterization and impact on outcome. A single-center cohort study C Bucelli, B Fattizzo, D Cattaneo, JA Giannotta, K Barbullushi, ... Frontiers in Oncology 11, 701604, 2021 | 2 | 2021 |
| Impact of Serum Immunoglobulin Subsets and Levels on Chronic Lymphocytic Leukemia Natural History: A Retrospective Multicentric Italian Experience L Laurenti, A Corbingi, I Innocenti, A Tomasso, R Pasquale, A Visentin, ... Blood 134, 3026, 2019 | 2 | 2019 |
| Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real‐life experience I Innocenti, A Mosca, A Tomasso, A Galitzia, L Scarfò, F Morelli, E Galli, ... HemaSphere 8 (12), e144, 2024 | | 2024 |
| First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different … F Autore, A Tedeschi, G Benevolo, V Mattiello, E Galli, N Danesin, R Rizzi, ... American journal of hematology, 2024 | | 2024 |
